Alpine Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.60 Cr
- Revenue Growth -84.92%
- Profit Growth -96.22%
- Ebitda -94.31%
- Net Worth 6.32%
- Total Assets -34.53%
About Alpine Biomedicals
Alpine Biomedicals Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 April 2017 (Seven years and nine months 26 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹6.60 Cr.
Abhinav Goyal, Gaurav Garg, Sahil Kalra, and One other member serve as directors at the Company.
Company Details
- Location
Ambala, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85200HR2017PTC068487
- Company No.
068487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Alpine Biomedicals Private Limited offer?
Alpine Biomedicals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Corona Test Kit, Sexual Wellness Products, Female Hygiene Products & Test Kits.
Who are the key members and board of directors at Alpine Biomedicals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sahil Kalra | Director | 25-Dec-2017 | Current |
Abhinav Goyal | Director | 01-Jan-2023 | Current |
Gaurav Garg | Director | 06-Apr-2017 | Current |
Amrita Sundaram | Director | 23-Jun-2021 | Current |
Financial Performance of Alpine Biomedicals.
Alpine Biomedicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 84.92% decrease. The company also saw a substantial fall in profitability, with a 96.22% decrease in profit. The company's net worth moved up by a moderate rise of 6.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Alpine Biomedicals?
In 2023, Alpine Biomedicals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.60 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 4.60 Cr
- Hdfc Bank Limited : 2.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
12 Jul 2024 | Others | ₹4.50 Cr | Open |
30 Sep 2021 | Hdfc Bank Limited | ₹2.00 Cr | Open |
06 Jun 2018 | Others | ₹1.00 M | Open |
How Many Employees Work at Alpine Biomedicals?
Alpine Biomedicals has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpine Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpine Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.